Total Pharmacy Interviews

With unprecedented changes to Medicare Part D plans at the top of the year, experts from ASCP help pharmacy businesses understand key provisions under the IRA.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

Discover how pharmacy teams are advancing stewardship, opioid safety, and survey readiness through clinical surveillance, competency-based education, and emerging AI tools that help reduce ADEs and improve patient outcomes.

Ron Lanton III, Esq, provides nuance to the current state of pharmacy sustainability and how the MFN drug pricing policy could impact the industry.

Ron Lanton III, Esq, discusses previous MFN drug pricing policies and why the free US drug market often yields higher patient costs.

Ron Lanton III, Esq, discusses the revamped version of the Trump Administration’s MFN drug pricing policy and why his second term may yield different outcomes.

From the COVID-19 pandemic through state-by-state expansion of scope, pharmacists have tapped into a variety of their clinical skills to bolster patient outcomes in their communities.

With the constant financial hurdles businesses face, the community pharmacy industry has struggled with finding new ways to innovate within its practices.

With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

In part 3 of our interview with Bill Wolfe, COO of WriteWise, he discusses the technology backing his team’s approach to forever changing how pharmacy benefits are distributed in the US.

Bill Wolfe, COO at WriteWise and former President of Aetna’s Pharmacy Management team, discusses the evolution of pharmacy benefits and where PBM and pharmacist roles fall in between.

Pharmacists are actively working to increase public awareness and acceptance of their expanded health care role through advocacy for legislative changes that recognize their critical contributions to patient care.

Pooja Babbrah, executive vice president of strategy and industry alignment at NCPDP, joined Drug Topics to discuss the power of pharmacy standards in helping patients, pharmacists, and more.

Chris Bell, JD, vice president of business operations at API Warehouse, discusses proactive approaches in preventing fraudulent threats and staying compliant with DSCSA.

Pharmacists advocate for standardized scope of practice, improved collaborative care models, and equitable reimbursement to enhance patient services across different states.

Calvin Hunsicker, founder & chief product officer at SureCost, discusses ongoing pharmacy procurement challenges in 2025 and how his company is helping businesses tackle common obstacles.

Community pharmacists are increasingly playing a vital role in expanding health care access by offering clinical services like chronic disease management, HIV prevention, and reproductive health care.

While the new guidelines are reserved for critical care pharmacists in the ICU, they can be applied to other practice areas, highlighting the crucial role pharmacists play in health care.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.

From the perspective of someone directly impacted by PBM practices, Bil Schmidtknecht shares his insights into the ways PBMs affect patients’ access to medications.

After sharing his son’s tragic story, Bil Schmidtknecht discusses the common ways the Big 3 PBMs operate and how smaller organizations are on the rise, becoming unlikely competitors.

Bil Schmidtknecht joined Drug Topics to share his son’s tragic story and how it motivated him to join the greater fight in putting the lives of patients at the forefront of health care.

Addressing the impacts on patients and the overall pharmacy market, Joey Mattingly, PharmD, MBA, PhD, discusses trends in pharmacies opening and closing across the country.

In part 3 of our interview with Joey Mattingly, PharmD, MBA, PhD, he discusses potential government policies for reducing pharmacy closures.